Published in Lancet on November 19, 2005
Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science (2015) 21.42
Childhood obesity and adult morbidities. Am J Clin Nutr (2010) 3.80
Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet (2009) 2.86
Environmental causes of esophageal cancer. Gastroenterol Clin North Am (2009) 2.80
Applying what we know to accelerate cancer prevention. Sci Transl Med (2012) 2.43
16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer (2011) 2.32
Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg (2008) 2.29
Cancer diagnosis in primary care. Br J Gen Pract (2010) 2.24
Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ (2011) 1.94
Communicating evidence-based information on cancer prevention to state-level policy makers. J Natl Cancer Inst (2011) 1.88
Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. Cancer Res (2009) 1.84
Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol (2012) 1.74
Environmental and occupational interventions for primary prevention of cancer: a cross-sectorial policy framework. Environ Health Perspect (2013) 1.54
Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med (2011) 1.49
Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patterns. Carcinogenesis (2007) 1.48
Trends in relative survival in patients with a diagnosis of hepatocellular carcinoma in Ontario: a population-based retrospective cohort study. CMAJ Open (2015) 1.43
Web-assisted tobacco interventions: empowering change in the global fight for the public's (e)Health. J Med Internet Res (2008) 1.36
Developmental reprogramming of cancer susceptibility. Nat Rev Cancer (2012) 1.35
Smoking uptake and prevalence in Ghana. Tob Control (2009) 1.34
Attributable causes of esophageal cancer incidence and mortality in China. PLoS One (2012) 1.31
Multi-organ Mapping of Cancer Risk. Cell (2016) 1.30
Psychosocial determinants of fruit and vegetable intake in adult population: a systematic review. Int J Behav Nutr Phys Act (2010) 1.27
1. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer (2011) 1.26
Prevalence of smoking and incidence of initiation in the Latin American adult population: the PLATINO study. BMC Public Health (2009) 1.24
Distributed usability evaluation of the Pennsylvania Cancer Atlas. Int J Health Geogr (2008) 1.22
Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency. BMC Int Health Hum Rights (2010) 1.20
Estimation of cancer incidence and mortality attributable to alcohol drinking in China. BMC Public Health (2010) 1.17
Joint effect of cigarette smoking and alcohol consumption on mortality. Prev Med (2007) 1.16
Cancer prevention research - then and now. Nat Rev Cancer (2009) 1.12
Smoking patterns in Ghanaian civil servants: changes over three decades. Int J Environ Res Public Health (2009) 1.11
Associations between variants of the 8q24 chromosome and nine smoking-related cancer sites. Cancer Epidemiol Biomarkers Prev (2008) 1.06
Socioeconomic inequalities in alcohol related cancer mortality among men: to what extent do they differ between Western European populations? Int J Cancer (2007) 1.05
Leptin and Adiponectin: new players in the field of tumor cell and leukocyte migration. Cell Commun Signal (2009) 1.04
Validity of recall of tobacco use in two prospective cohorts. Am J Epidemiol (2010) 1.03
Occupational exposures contribute to educational inequalities in lung cancer incidence among men: Evidence from the EPIC prospective cohort study. Int J Cancer (2010) 1.03
ZIC1 modulates cell-cycle distributions and cell migration through regulation of sonic hedgehog, PI(3)K and MAPK signaling pathways in gastric cancer. BMC Cancer (2012) 1.00
Epidemiology, incidence and mortality of lung cancer and their relationship with the development index in the world. J Thorac Dis (2016) 0.99
Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health (2012) 0.98
Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells. PLoS One (2014) 0.98
Development of an interactive, Web-delivered system to increase provider-patient engagement in smoking cessation. J Med Internet Res (2011) 0.98
Pathogenesis, prevention, diagnosis and treatment of breast cancer. World J Clin Oncol (2014) 0.98
Global prevention of environmental and occupational cancer. Environ Health Perspect (2011) 0.97
Human development index is associated with mortality-to-incidence ratios of gastrointestinal cancers. World J Gastroenterol (2013) 0.96
Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007. BMC Cancer (2012) 0.95
MicroRNA-206 suppresses gastric cancer cell growth and metastasis. Cell Biosci (2014) 0.95
Smoking and alcohol drinking increased the risk of esophageal cancer among Chinese men but not women in a high-risk population. Cancer Causes Control (2011) 0.95
Gastric cancer and the epoch of immunotherapy approaches. World J Gastroenterol (2015) 0.94
Cancer, physical activity, and exercise. Compr Physiol (2012) 0.94
MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ. Cell Death Dis (2015) 0.94
Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer (2010) 0.94
Residual-QSAR. Implications for genotoxic carcinogenesis. Chem Cent J (2011) 0.94
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer. Cardiorenal Med (2012) 0.94
Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN. Cancers (Basel) (2014) 0.93
Cervical cancer screening among university students in South Africa: a theory based study. PLoS One (2014) 0.92
Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers. Am J Pathol (2012) 0.92
Fostering multiple healthy lifestyle behaviors for primary prevention of cancer. Am Psychol (2015) 0.92
The catalase C-262T gene polymorphism and cancer risk: a systematic review and meta-analysis. Medicine (Baltimore) (2015) 0.90
Information seeking from media and family/friends increases the likelihood of engaging in healthy lifestyle behaviors. J Health Commun (2013) 0.90
Variation in blame attributions across different cancer types. Cancer Epidemiol Biomarkers Prev (2010) 0.90
Lay representations of cancer prevention and early detection: associations with prevention behaviors. Prev Chronic Dis (2009) 0.89
Patterns and correlates of multiple risk factors for adult-onset cancer among adolescents(1). J Child Health Care (2012) 0.89
Single nucleotide polymorphisms of ADH1B, ADH1C and ALDH2 genes and esophageal cancer: a population-based case-control study in China. Int J Cancer (2012) 0.89
The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise. Obes Rev (2015) 0.88
Estimating population attributable fractions to quantify the health burden of obesity. Ann Epidemiol (2014) 0.88
Risk-based indicators of Canadians' exposures to environmental carcinogens. Environ Health (2013) 0.87
Modeling cancer patient populations in mice: complex genetic and environmental factors. Drug Discov Today Dis Models (2008) 0.87
Explanation-aware computing of the prognosis for breast cancer supported by IK-DCBRC: Technical innovation. Electron Physician (2014) 0.87
Evaluation of the Families SHARE workbook: an educational tool outlining disease risk and healthy guidelines to reduce risk of heart disease, diabetes, breast cancer and colorectal cancer. BMC Public Health (2015) 0.87
Attributable fraction of alcohol consumption on cancer using population-based nationwide cancer incidence and mortality data in the Republic of Korea. BMC Cancer (2014) 0.87
Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer. PLoS One (2012) 0.86
The disease burden attributable to smoking in the state of Rio de Janeiro, Brazil in 2000. Clinics (Sao Paulo) (2008) 0.86
Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures. EPMA J (2010) 0.86
Janus kinase 2 polymorphisms are associated with risk in patients with gastric cancer in a Chinese population. PLoS One (2013) 0.86
Serum glucose and fructosamine in relation to risk of cancer. PLoS One (2013) 0.85
Polymorphisms of CHRNA5-CHRNA3-CHRNB4 Gene Cluster and NSCLC Risk in Chinese Population. Transl Oncol (2012) 0.85
Association between LMP2 and LMP7 gene polymorphisms and the risk of gastric cancer: A case-control study. Oncol Lett (2015) 0.85
Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival. Oncotarget (2015) 0.85
Emerging molecular basis of hematogenous metastasis in gastric cancer. World J Gastroenterol (2016) 0.84
Restoration of miR-1228* expression suppresses epithelial-mesenchymal transition in gastric cancer. PLoS One (2013) 0.84
miR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression. Exp Ther Med (2014) 0.84
Diverging trends in educational inequalities in cancer mortality between men and women in the 2000s in France. BMC Public Health (2013) 0.84
Body mass index and serum proteomic profile in breast cancer and healthy women: a prospective study. PLoS One (2012) 0.83
Individual and social determinants of multiple chronic disease behavioral risk factors among youth. BMC Public Health (2012) 0.83
Alcohol as a risk factor for cancer: existing evidence in a global perspective. J Prev Med Public Health (2015) 0.83
Evaluation of a novel functional single-nucleotide polymorphism (rs35010275 G>C) in MIR196A2 promoter region as a risk factor of gastric cancer in a Chinese population. Medicine (Baltimore) (2014) 0.83
Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer. Exp Ther Med (2011) 0.83
Disparity in cancer care: a Canadian perspective. Curr Oncol (2012) 0.82
Worldwide Burden of Gastric Cancer Attributable to Tobacco Smoking in 2012 and Predictions for 2020. Dig Dis Sci (2015) 0.82
Design of a randomized controlled trial for multiple cancer risk behaviors among Spanish-speaking Mexican-origin smokers. BMC Public Health (2013) 0.82
Investigating the role of the general practitioner in cancer prevention: a mixed methods study. BMC Fam Pract (2013) 0.82
Alcohol consumption and risk of myelodysplastic syndromes: A meta-analysis of epidemiological studies. Mol Clin Oncol (2014) 0.81
Human papillomavirus in head and neck cancer. Cancers (Basel) (2014) 0.81
Pulmonary tuberculosis and lung cancer risk in current smokers: the Seoul Male Cancer Cohort Study. J Korean Med Sci (2013) 0.81
Motivations toward smoking cessation, reasons for relapse, and modes of quitting: results from a qualitative study among former and current smokers. Patient Prefer Adherence (2014) 0.81
Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation. Diabetol Metab Syndr (2011) 0.81
Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection. Curr Epidemiol Rep (2016) 0.81
Poor awareness of risk factors for cancer in Irish adults: results of a large survey and review of the literature. Oncologist (2015) 0.80
Urinary 1-hydroxypyrene as a biomarker to carcinogenic polycyclic aromatic hydrocarbon exposure. Biomark Cancer (2012) 0.80
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet (2006) 37.83
Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet (2010) 33.69
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Maternal and child undernutrition: global and regional exposures and health consequences. Lancet (2008) 26.44
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Household catastrophic health expenditure: a multicountry analysis. Lancet (2003) 20.07
Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet (2013) 18.02
Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet (2012) 17.62
Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76
Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ (2005) 15.50
Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (2011) 14.16
Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet (2009) 13.41
Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4. Lancet (2010) 12.28
The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
Public financing of health in developing countries: a cross-national systematic analysis. Lancet (2010) 11.22
Global burden of blood-pressure-related disease, 2001. Lancet (2008) 11.09
Estimates of global mortality attributable to smoking in 2000. Lancet (2003) 10.52
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43
Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2014) 10.06
Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet (2006) 9.85
Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States. PLoS Med (2006) 8.70
GBD 2010: design, definitions, and metrics. Lancet (2012) 8.64
Fine-particulate air pollution and life expectancy in the United States. N Engl J Med (2009) 8.36
Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet (2012) 8.22
What has made the population of Japan healthy? Lancet (2011) 8.18
50-year trends in smoking-related mortality in the United States. N Engl J Med (2013) 7.80
Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (2011) 7.71
Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70
Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 7.62
Can we achieve Millennium Development Goal 4? New analysis of country trends and forecasts of under-5 mortality to 2015. Lancet (2007) 6.72
Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet (2007) 6.45
Trends in national and state-level obesity in the USA after correction for self-report bias: analysis of health surveys. J R Soc Med (2006) 6.11
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med (2013) 6.04
Measuring the global burden of disease. N Engl J Med (2013) 5.84
Global sodium consumption and death from cardiovascular causes. N Engl J Med (2014) 5.83
Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North America. Lancet (2006) 5.70
Civil registration systems and vital statistics: successes and missed opportunities. Lancet (2007) 5.67
Increased educational attainment and its effect on child mortality in 175 countries between 1970 and 2009: a systematic analysis. Lancet (2010) 5.36
Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet (2003) 5.26
Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet (2011) 5.13
Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis (2007) 4.87
Stillbirths: the way forward in high-income countries. Lancet (2011) 4.69
Rethinking the "diseases of affluence" paradigm: global patterns of nutritional risks in relation to economic development. PLoS Med (2005) 4.64
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLoS Med (2007) 4.51
Exposure assessment for estimation of the global burden of disease attributable to outdoor air pollution. Environ Sci Technol (2012) 4.44
Monitoring global health: time for new solutions. BMJ (2004) 4.39
Validation of the symptom pattern method for analyzing verbal autopsy data. PLoS Med (2007) 4.35
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet (2016) 4.29
Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment. Lancet (2006) 4.26
Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol (2005) 4.20
Inequalities in non-communicable diseases and effective responses. Lancet (2013) 4.18